Editas Medicine Inc (LTS:0IFK)
$ 3.5 (0%) Market Cap: 560.14 Mil Enterprise Value: 453.79 Mil PE Ratio: 0 PB Ratio: 80.89 GF Score: 48/100

Editas Medicine Inc Annual Shareholders Meeting Transcript

Jun 17, 2026 / 12:30PM GMT
Release Date Price: $2.56 (+6.67%)
Operator

Welcome to the 2026 Annual Meeting of Editas Medicine Stockholders.

I would now like to introduce Jessica Hopfield, Chair of the Board.

Jessica Hopfield
Editas Medicine Inc - Independent Chairman of the Board

Good morning, and welcome to the 2026 Annual Meeting of Stockholders of Editas Medicine. I am Jessica Hopfield, Chair of the Board, and I will be presiding over this meeting.

At this time, I call the meeting to order.

We are pleased to have everyone join this live webcast of our Annual Meeting, which is being held in an all-virtual format.

We have designed this meeting to provide stockholders the same rights and opportunities to participate as they would have at an in-person meeting.

Before we get to the formal business of the meeting, I would like to make some introductions. Present at the meeting today are Bernadette Connaughton, Andrew Hirsch, Dr. Elliot Levy, and Dr. David Scadden, each a director of Editas Medicine.

In addition... I'm pleased to be joined by our President and Chief Executive

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot